Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps he is taking with Cabinet colleagues to fund research into lobular breast cancer.

The Government doesn’t ringfence funding for specific diseases but is committed to funding cancer research, including lobular breast cancer. The Department of Health and Social Care spent £121.8 million in 2022/23 on cancer research through the National Institute for Health and Care Research.

The Department for Science, Innovation and Technology funds cancer research via UK Innovation and Research (UKRI). UKRI invests approximately £200 million annually into cancer research, of which £10m per year is for breast cancer research.

Office for Life Sciences’ Cancer Healthcare Goals programme funds innovations at the earlier stages of the research and development pipeline. Such innovations will have the potential to diagnose multiple tumour types, including breast cancer.

We have allocated £1.3 million of funding for a National Institute of Health and Care Research (NIHR) project that will assess the effectiveness of a new form of MRI scan to detect breast cancers that have been missed by mammograms.

Further NIHR research infrastructure funding supports Biomedical Research Centres and the NIHR Research Delivery Network, which has enabled delivery of 10 lobular breast-cancer studies.